SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is experiencing intense discussion ahead of record Super Bowl betting volume, with community sentiment sharply divided between the escalating competitive challenge from prediction markets and the highly anticipated upcoming earnings report, especially as the company expands its own prediction offerings.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

DOJ scrutiny of Netflix's Warner Bros. Discovery bid is shifting market sentiment, with the community actively discussing how this could favor Paramount Skydance's counter-offer, which is further buoyed by the highly successful debut of UFC content on Paramount+.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following a high-impact Super Bowl commercial for its Briumvi drug and strong preliminary revenue guidance, fueling community discussion about Briumvi's growing market share and best-in-class profile. Many investors are highlighting its efficacy and safety against competitor drug concerns, yet express frustration over the stock's valuation disconnect and actively discuss a potential buyout to realize its full value.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after announcing a significant $250 million Equity Line of Credit (ELOC) that extends its capital runway through 2028, sparking widespread community discussion about a potential short squeeze and a return to historically high price levels. While many anticipate substantial gains and highlight the company's molecular-marker technology and blockchain integration, others express concerns regarding potential share dilution from the financing agreement.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI), an AI memecoin backed by Matt Furie, is trending with strong community enthusiasm following new exchange listings on platforms like Bitget and KuCoin Alpha, a recent developer update to counter selling pressure, and an ongoing 12-week marketing campaign including a new podcast and a Crypto Banter partnership, with many anticipating it to be the "next PEPE" and aspiring for Tier 1 exchange listings.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending due to its polarizing Super Bowl commercial, which sparked widespread debate on its effectiveness, ranging from a perceived waste of money to a genius marketing play for attention. This commercial buzz, alongside significant volatility in the broader crypto market and anticipation for its upcoming earnings, is driving intense community discussion regarding COIN's immediate performance.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is surging after announcing its first-ever quarterly operating profit and achieving the significant milestone of 100 million battery swaps, sparking community debate over its suppressed valuation amidst continued analyst skepticism.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings Inc. is soaring after reporting an impressive earnings beat and strong forward guidance, fueling investor excitement around its critical role in providing optical components like circuit switches and co-packaged optics for rapidly expanding AI data centers. The market is buzzing with bullish sentiment and numerous analyst upgrades, recognizing LITE as a key beneficiary of the 'AI plumbing' supercycle.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending after discontinuing its recently launched compounded semaglutide pill following regulatory scrutiny and legal threats, fueling a polarized community debate between those anticipating further stock decline due to perceived management missteps and others expecting a rebound as regulatory overhang is removed and a Super Bowl ad airs.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as futures indicate strong bullish momentum leading into the week, while the community is widely discussing the Super Bowl halftime show's perceived, albeit speculative, impact on market sentiment alongside anticipation for upcoming jobs and inflation reports.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Twin Capital Management Inc. Sells 5,246 Shares of Biogen Inc. $BIIB

Twin Capital Management Inc. decreased its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 43.6% in the third quarter, according to the company in its most recent 13F filing with the...

Penserra Capital Management LLC Has $706,000 Holdings in Biogen Inc. $BIIB

Penserra Capital Management LLC grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 41,941.7% during the third quarter, according to its most recent 13F filing with the SEC. The...

Stifel Nicolaus Increases Biogen (NASDAQ:BIIB) Price Target to $214.00

Stifel Nicolaus lifted their price objective on shares of Biogen from $202.00 to $214.00 and gave the company a "buy" rating in a research note on Friday...

Why Biogen Stock Surged Almost 9% Higher on Friday

Key PointsThe biotech published its last set of financials for 2025...

Biogen (NASDAQ:BIIB) Posts Quarterly Earnings Results, Beats Estimates By $0.27 EPS

Biogen (NASDAQ:BIIB - Get Free Report) issued its earnings results on Friday. The biotechnology company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.72 by...

BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View

Biogen tops Q4 earnings and sales estimates, and shares rise after the company issues an encouraging 2026 adjusted EPS outlook despite revenue pressure.

Pre-Markets Open in Green to Close the Week

Pre-Markets Open in Green to Close the Week.

Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump

Biogen beat fourth-quarter earnings and revenue estimates as growth from Leqembi, Skyclarys, and Zurzuvae offset declining multiple sclerosis sales, while the company forecast higher 2026...

Pre-Markets Rebounding Ahead of Super Bowl Sunday

We're seeing is a slight uptick at this hour for companies like Draft Kings (DKNG) and FanDuel parent Flutter (FLUT).

Biogen (NASDAQ:BIIB) Sets New 12-Month High Following Earnings Beat

Biogen (NASDAQ:BIIB) Sets New 1-Year High on Strong Earnings...

$BIIB Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.33 down -118.03% YoY
• Reported revenue of $2.28B down -7.14% YoY
• Biogen expects full year 2026 Non-GAAP diluted EPS to be between $15.25 and $16.25. Total revenue is anticipated to decline by a mid-single digit percentage compared to full year 2025.

Stocktwits

Biogen Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$0.33 down -118.03% YoY
• Reported revenue of $2.28B down -7.14% YoY
• Biogen expects full year 2026 Non-GAAP diluted EPS to be between $15.25 and $16.25. Total revenue is anticipated to decline by a mid-single digit percentage compared to full year 2025.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

What will be the S&P 500’s next 5% move?

Current Price	$198.60
Prev Close	$185.36
Open	$187.01
Dividend Yield	0.00%
50-Day Moving Average	$177.52
Beta	0.63
Avg. Volume	1.56M
PE Ratio	22.85

52-Week High	$202.41
52-Week Low	$110.04
Market Capitalization	$34.3B
EPS (Annual)	$8.79
Price to Book	1.62
Revenue Per Employee	$1.27M
Enterprise Value/EBITDA	N/A

BIIB
Biogen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIIB News

BIIBBiogen Inc